Pyrazole derivatives and their use as cannabinoid receptor mediators

US10329259B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• George Kunos · Bethesda, US
• Malliga Iyer · Germantown, US
• Resat Cinar · Bethesda, US
• Kenner C. Rice · Bethesda, US

Key dates

• Filing date: May 8, 2015
• Grant date: Jun 25, 2019
• Expiry date: Sep 7, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P19/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein X and Y are each independently selected from optionally-substituted aryl, optionally-substituted heteroaryl, optionally-substituted cycloalkyl, optionally-substituted heterocycloalkyl, or optionally-substituted alkyl;